PharmaLex Belgium

Rue Edouard Belin 5

1435 Mont-Saint-Guibert

BE

PharmaLex Belgium

Foundation date

19/12/2016

Sector

#Biotechnology / R&D Services

Subsector

Pharmalex is a CRO specialized in Applied « Modeling & Statistics » for informed and timely decision making in Life Sciences.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023